Results 81 to 90 of about 22,646 (193)

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6509-6532, August 2026.
ABSTRACT Aims To provide a comprehensive overview of the cardiovascular and renal effects of glucose‐dependent insulinotropic polypeptide (GIP) by integrating its physiological role with recent human trial data on tirzepatide, the first dual GIP and glucagon‐like peptide‐1 (GLP‐1) receptor agonist.
Michelantonio De Fano, Line L. Haurum, Christine R. Schwarz, Francesca Porcellati, Andreas Andersen   +4 more
wiley   +1 more source

Procedure‐specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Pancreatic neuroendocrine tumors (PanNETs) are increasingly detected, and the optimal extent of resection remains uncertain because perioperative burden and oncologic assessment may differ by procedure. Enucleation (EN) and central pancreatectomy (CP) are often grouped together as parenchyma‐sparing resections (PSRs) despite substantial ...
Aya Maekawa, Giampaolo Perri, Stefano Partelli, Charles de Ponthaud, Safi Dokmak, Carsten Jäger, Maria Lavinia Luzietti, Alessio Marchetti, Valentina Andreasi, Anna Battistella, Bengi Su Yilmaz, Andrea Sheel, Kunal Rajput, Haiyi Hu, Umberto Cillo, Alain Sauvanet, Helmut Friess, Ryan D. Baron, Sébastien Gaujoux, Massimo Falconi, Giovanni Marchegiani   +20 more
wiley   +1 more source

Neuronal reprogramming of mouse and human fibroblasts using transcription factors involved in suprachiasmatic nucleus development

iScience
Summary: The hypothalamic suprachiasmatic nucleus (SCN) is composed of heterogenous populations of neurons that express signaling peptides such as vasoactive intestinal polypeptide (VIP) and arginine vasopressin (AVP) and regulate circadian rhythms in ...
Masatoshi Hirayama, Ludovic S. Mure, Hiep D. Le, Satchidananda Panda   +3 more
doaj   +1 more source

Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma

Journal of Indian Association of Pediatric Surgeons
We present a rare case of a 17-month-old child diagnosed with MS-stage neuroblastoma and associated chronic diarrhea due to elevated vasoactive intestinal peptide (VIP) levels.
Josy Thomas, Nitin James Peters, Aravind Sekar, Deepak Bansal, Jitender Singh, Ravi P. Kanojia, J. K. Mahajan   +6 more
doaj   +1 more source

From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment

Current Research in Biotechnology
Alzheimer’s Disease (AD) represents a significant neurodegenerative challenge with current therapeutic strategies primarily focused on symptomatic management.
Artur Galushkin, Illana Gozes
doaj   +1 more source

Expression of motilin and vasoactive intestinal peptide in diverticular disease of the colon

Терапевтический архив
Aim. To determine the role of the expression of motilin and vasoactive intestinal peptide (VIP) in diverticular disease of the large intestine (DD). Materials and methods. Examined 45 patients with DD.
Mikhail A. Osadchuk, Ekaterina D. Mironova, Iuliia S. Krylova, Pavel V. Gulyaev, Regina A. Akhtyamova   +4 more
doaj   +1 more source

Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer

Theranostics, 2012
Human cancer cells overexpress many peptide receptors as molecular targets. Radiolabeled peptides that bind with high affinity and specificity to the receptors on tumor cells hold great potential for both diagnostic imaging and targeted radionuclide ...
M. Fani, H. R. Maecke, S. M. Okarvi
doaj  

Vasoactive intestinal peptide exerts therapeutic action by regulating PTEN in a model of Sjögren's disease. [PDF]

Immun Inflamm Dis, 2023
Li Y, Zhu W, Lin R, Zhao J, Wang Y.
europepmc   +1 more source

Pancreatic Vasoactive Intestinal Peptide-Producing Tumor as a Rare Cause of Acute Diarrhea and Severe Hypokalemia. [PDF]

J Med Cases, 2023
Giampatzis V, Kotsiari C, Bostantzis P, Chrisoulidou A, Fotiadou A, Loti S, Papantoniou S, Papadopoulou P.   +7 more
europepmc   +1 more source

A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure. [PDF]

Lancet Respir Med, 2023
Lee WL, Slutsky AS.
europepmc   +1 more source